Thanks for the links. This is certainly a very interesting development here. One sniff of success in this trial partnership, and we could be seeing revenue quite fast as markets in Asia are easier to access than US. But then, if the results are compelling, the US FDA may well fast track the drug to market as there is currently no successful treatment for solid tumors.
As I said in a previous post, even at 50 cents, the IMU train has not departed from the station yet. A market cap of $3bn is peanut if one is successful in trials for drugs that has a market potential of more than US$400bn! Chew on that
Ann: Imugene and Eureka Therapeutics onCARlytics Collaboration, page-25
-
- There are more pages in this discussion • 36 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.9¢ |
Change
0.005(9.26%) |
Mkt cap ! $433.6M | |||
| Open | High | Low | Value | Volume |
| 5.5¢ | 5.9¢ | 5.4¢ | $1.489M | 25.99M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 35252 | 5.9¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 6.0¢ | 1753430 | 24 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |